Literature DB >> 16143687

Diagnosis and management of gout: a rational approach.

E Suresh1.   

Abstract

Gout is one of the best understood among the rheumatological disorders and one of the most satisfying to treat. Even non-specialists should be able to diagnose and treat most patients provided some important principles are appreciated. Management of a minority of patients, including those with renal impairment is difficult and often unsatisfactory, because of restricted treatment options. In this paper, the basic principles underlying the diagnosis and management of gout are discussed first, followed by practical approaches.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16143687      PMCID： PMC1743349          DOI： 10.1136/pgmj.2004.030692

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  90 in total

Review 1.  Uric acid: is it a risk factor for cardiovascular disease?

Authors:  M W Rich
Journal:  Am J Cardiol       Date:  2000-04-15       Impact factor: 2.778

2.  Identification of the causes of persistent hyperuricaemia.

Authors:  B T Emmerson
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

Review 3.  The management of gout.

Authors:  B T Emmerson
Journal:  N Engl J Med       Date:  1996-02-15       Impact factor: 91.245

4.  Hyperuricemia, acute gout, renal insufficiency and urate nephrolithiasis due to starvation.

Authors:  E J Drenick
Journal:  Arthritis Rheum       Date:  1965-10

5.  The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis.

Authors:  Wako Urano; Hisashi Yamanaka; Hiroshi Tsutani; Hiroshi Nakajima; Yuko Matsuda; Atsuo Taniguchi; Masako Hara; Naoyuki Kamatani
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

6.  Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Authors:  K R Hande; R M Noone; W J Stone
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

7.  Hyperuricaemia, gout and kidney function in New Zealand Maori men.

Authors:  T Gibson; R Waterworth; P Hatfield; G Robinson; K Bremner
Journal:  Br J Rheumatol       Date:  1984-11

8.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

9.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

10.  Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.

Authors:  E Pascual
Journal:  Arthritis Rheum       Date:  1991-02
View more
  10 in total

Review 1.  The radiographic and MRI features of gout referred as suspected soft tissue sarcoma: a review of the literature and findings from 27 cases.

Authors:  Neil Upadhyay; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2014-09-24       Impact factor: 2.199

2.  Clinical effect and action mechanism of Weicao Capsule in treating gout.

Authors:  En-feng Song; Qiong Xiang; Kai-ming Ren; Jia-cai Hu; Fan Wu; Mei-fang Gong; Hong Zhang; Hui-min Bi
Journal:  Chin J Integr Med       Date:  2008-08-06       Impact factor: 1.978

3.  Laser treatment of synovial inflammatory process in experimentally induced microcrystalline arthritis in Wistar rats.

Authors:  Débora Mara Fortes Bartoli; Airton Luiz Felizatti; Fernando Russo Costa do Bomfim; Julia Leme Bovo; Andrea Aparecida de Aro; Maria Esméria Corezzola do Amaral; Marcelo Augusto Marretto Esquisatto
Journal:  Lasers Med Sci       Date:  2020-06-10       Impact factor: 3.161

4.  Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

Authors:  Naomi Schlesinger; Eduardo Mysler; Hsiao-Yi Lin; Marc De Meulemeester; Jozef Rovensky; Udayasankar Arulmani; Alison Balfour; Gerhard Krammer; Peter Sallstig; Alexander So
Journal:  Ann Rheum Dis       Date:  2011-05-03       Impact factor: 19.103

5.  Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.

Authors:  Paola Primatesta; Estel Plana; Dietrich Rothenbacher
Journal:  BMC Musculoskelet Disord       Date:  2011-05-20       Impact factor: 2.362

6.  Patient and clinical characteristics associated with gout flares in an integrated healthcare system.

Authors:  Nazia Rashid; Gerald D Levy; Yi-Lin Wu; Chengyi Zheng; River Koblick; T Craig Cheetham
Journal:  Rheumatol Int       Date:  2015-05-20       Impact factor: 2.631

7.  Raman Spectroscopy Applied to the Noninvasive Detection of Monosodium Urate Crystal Deposits.

Authors:  Declan J Curran; Laurence Rubin; Mark R Towler
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2015-08-18

8.  The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece.

Authors:  Evangelos Theotikos; Ioannis Raftakis; Antonia Elezoglou; Christodoulos Antoniadis
Journal:  Mediterr J Rheumatol       Date:  2017-03-28

Review 9.  The importance of ultrasound in identifying and differentiating patients with early inflammatory arthritis: a narrative review.

Authors:  Gurjit S Kaeley; Catherine Bakewell; Atul Deodhar
Journal:  Arthritis Res Ther       Date:  2020-01-02       Impact factor: 5.156

10.  Clinical features and recurrent attack in gout patients according to serum urate levels during an acute attack.

Authors:  Jung Sun Lee; Oh Chan Kwon; Ji Seon Oh; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo; Seokchan Hong
Journal:  Korean J Intern Med       Date:  2019-01-28       Impact factor: 2.884
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.